-
1
-
2
NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness
Published 2018-01-01Get full text
Article -
3
-
4
Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients
Published 2012-01-01Get full text
Article -
5
Safety and Efficacy of 188-Rhenium-Labeled Antibody to Melanin in Patients with Metastatic Melanoma
Published 2013-01-01Get full text
Article -
6
-
7
Patients with Age-related Macular Degeneration Have Increased Susceptibility to Valvular Heart Disease
Published 2025-03-01Get full text
Article -
8
-
9
Association of Adult Atopic Dermatitis with Impaired Oral Health and Oral Dysbiosis: A Case-Control Study
Published 2025-02-01Get full text
Article -
10
-
11
Low dose ATG-Fresenius for GVHD prophylaxis: a comparative study with ATG-Thymoglobulin
Published 2025-01-01Get full text
Article -
12
Association of chronic heart failure with mortality in old intensive care patients suffering from Covid‐19
Published 2022-06-01Get full text
Article -
13
Subclinical imaging activity in multiple sclerosis patients during war‐related psychological stress
Published 2025-01-01“…Data were collected from medical records and MRI scans at Hadassah Medical Center. MRI scans were classified as active if new or enlarging T2 lesions and/or enhancing T1 lesions were present. …”
Get full text
Article -
14
-
15
Long-term Breast Shape Analysis After Short-scar Reduction Mammaplasty: A Critical View
Published 2025-01-01Get full text
Article -
16
Parameters Suggesting Spontaneous Passage of Stones from Common Bile Duct: A Retrospective Study
Published 2019-01-01“…Data was retrospectively collected for all patients who were hospitalized with clinical, laboratory, or ultrasonographic evidence of choledocholithiasis and who underwent magnetic resonance cholangiopancreatography (MRCP) in Hadassah Medical Center between 2005 and 2011. The patients were classified into 4 groups: group A (positive MRCP and positive ERCP), group B (positive MRCP but negative ERCP), group C (positive MRCP but did not undergo ERCP), and group D (negative MRCP that did not undergo ERCP) for choledocholithiasis. …”
Get full text
Article -
17